{"log_id": 6700453280586831662, "direction": 0, "words_result_num": 39, "words_result": [{"probability": {"variance": 0.005204, "average": 0.972321, "min": 0.626859}, "location": {"width": 773, "top": 261, "height": 31, "left": 206}, "words": "血管神经性水肿伴有喉部水肿可能导致死亡。当水肿发生在舌、声门和/或喉部时,可"}, {"probability": {"variance": 0.000291, "average": 0.991474, "min": 0.91106}, "location": {"width": 813, "top": 303, "height": 27, "left": 165}, "words": "能引起气道阻塞,应立即给予适当治疗,包括诸如皮下注射1:1000肾上腺素溶液(0.3毫"}, {"probability": {"variance": 0.001596, "average": 0.986751, "min": 0.798193}, "location": {"width": 471, "top": 345, "height": 25, "left": 166}, "words": "升-0.5毫升)和/或立即采取保持呼吸道通畅的措施"}, {"probability": {"variance": 0.000215, "average": 0.99539, "min": 0.91178}, "location": {"width": 772, "top": 385, "height": 27, "left": 207}, "words": "有与血管紧张素置换酶抑制剂治疗无关的血管神经性水肿病史的人,在使用血管紧张素"}, {"probability": {"variance": 5.7e-05, "average": 0.995446, "min": 0.967473}, "location": {"width": 678, "top": 424, "height": 28, "left": 165}, "words": "转换酶抑制剂时,发生血管神经性水肿的危险性可能性增高(参阅禁忌症)"}, {"probability": {"variance": 0.000527, "average": 0.989769, "min": 0.903874}, "location": {"width": 372, "top": 466, "height": 24, "left": 237}, "words": "用膜翅目动物的毒液脱敏时的过敏样反应"}, {"probability": {"variance": 0.001063, "average": 0.992936, "min": 0.795496}, "location": {"width": 771, "top": 503, "height": 31, "left": 208}, "words": "当用膜翅日动物的毒液对使用血管紧张素转换酶抑制剂治疗的病人进行脱敏时,可能发"}, {"probability": {"variance": 6.5e-05, "average": 0.995133, "min": 0.955324}, "location": {"width": 815, "top": 541, "height": 35, "left": 163}, "words": "生危及生命的过敏样反应,这种情况较罕见。在每次脱敏前,暂时停用血管紧张素转换酶抑"}, {"probability": {"variance": 2e-06, "average": 0.998129, "min": 0.996083}, "location": {"width": 190, "top": 588, "height": 27, "left": 166}, "words": "制剂可避免这一反应"}, {"probability": {"variance": 1e-05, "average": 0.997423, "min": 0.990327}, "location": {"width": 147, "top": 628, "height": 26, "left": 239}, "words": "血液透析的病人"}, {"probability": {"variance": 0.000257, "average": 0.992884, "min": 0.925267}, "location": {"width": 754, "top": 660, "height": 37, "left": 206}, "words": "用高透量膜(如AN69)进行透析的同时,使用血管紧张素转换酶抑制剂治疗的病人"}, {"probability": {"variance": 0.000183, "average": 0.993361, "min": 0.921111}, "location": {"width": 764, "top": 700, "height": 37, "left": 166}, "words": "曾报告过有类过敏反应发生。对这类病人应考虑用另一类型透析膜或用另一类降压药"}, {"probability": {"variance": 0.019728, "average": 0.916372, "min": 0.673113}, "location": {"width": 73, "top": 751, "height": 24, "left": 209}, "words": "7.咳嗽"}, {"probability": {"variance": 9e-06, "average": 0.99781, "min": 0.9877}, "location": {"width": 774, "top": 780, "height": 38, "left": 207}, "words": "据报道,用血管紧张素转换酶抑制剂能引起咳嗽,其特点是无痰、持续、停药后可能消"}, {"probability": {"variance": 0.00018, "average": 0.99337, "min": 0.928612}, "location": {"width": 700, "top": 821, "height": 39, "left": 168}, "words": "失。在鉴别诊断咳嗽时,应考虑到血管紧张素转换酶抑制剂引起咳嗽的可能性"}, {"probability": {"variance": 3.4e-05, "average": 0.996231, "min": 0.982682}, "location": {"width": 126, "top": 871, "height": 26, "left": 209}, "words": "8.手术/麻醉"}, {"probability": {"variance": 0.000107, "average": 0.994555, "min": 0.94803}, "location": {"width": 773, "top": 899, "height": 42, "left": 209}, "words": "对于正在进行大手术或使用可能引起低血压的麻醉药物进行麻醉的病人,依那普利阻断"}, {"probability": {"variance": 0.010184, "average": 0.976707, "min": 0.352514}, "location": {"width": 803, "top": 939, "height": 42, "left": 170}, "words": "由于代偿性肾素释放引起的血管紧张素的生成。如果发生低血压,且考虑是上述机制所致"}, {"probability": {"variance": 2e-06, "average": 0.998007, "min": 0.994915}, "location": {"width": 231, "top": 991, "height": 29, "left": 171}, "words": "则应扩充血容量加以纠正"}, {"probability": {"variance": 9.9e-05, "average": 0.994492, "min": 0.961802}, "location": {"width": 274, "top": 1029, "height": 32, "left": 212}, "words": "血清钾一参阅药物的相互作用"}, {"probability": {"variance": 0, "average": 0.99894, "min": 0.998374}, "location": {"width": 44, "top": 1076, "height": 24, "left": 213}, "words": "叶酸"}, {"probability": {"variance": 0.000189, "average": 0.992615, "min": 0.93363}, "location": {"width": 733, "top": 1090, "height": 54, "left": 212}, "words": "服用本品期间,同服其他含有叶酸的复合维生素类药物或保健食品请咨询医师"}, {"probability": {"variance": 0.02272, "average": 0.947533, "min": 0.471301}, "location": {"width": 292, "top": 1151, "height": 32, "left": 214}, "words": "马来酸依那普利叶酸片魁"}, {"probability": {"variance": 0.000389, "average": 0.987724, "min": 0.938258}, "location": {"width": 215, "top": 1189, "height": 32, "left": 213}, "words": "1.叶酸降低同型半胱"}, {"probability": {"variance": 0.011489, "average": 0.69078, "min": 0.583591}, "location": {"width": 37, "top": 1178, "height": 39, "left": 435}, "words": "酸的"}, {"probability": {"variance": 0.016336, "average": 0.913052, "min": 0.602757}, "location": {"width": 443, "top": 1177, "height": 38, "left": 545}, "words": "四四气酸还原酶( MTHFR)基因C677T多态"}, {"probability": {"variance": 0.024769, "average": 0.913056, "min": 0.429145}, "location": {"width": 807, "top": 1211, "height": 49, "left": 172}, "words": "性的显著影响,纯合突变基的果普利叶酸片后,效果更好"}, {"probability": {"variance": 0.017376, "average": 0.930159, "min": 0.392476}, "location": {"width": 779, "top": 1252, "height": 56, "left": 213}, "words": "2.本品可与其他降药特别是利尿剂合用降压作用明显增强,但不宜与潴钾利尿剂"}, {"probability": {"variance": 0.000108, "average": 0.986398, "min": 0.975986}, "location": {"width": 46, "top": 1317, "height": 24, "left": 176}, "words": "合用"}, {"probability": {"variance": 0.017738, "average": 0.954139, "min": 0.406165}, "location": {"width": 777, "top": 1337, "height": 47, "left": 215}, "words": "3.个别病人,尤其是在应用利尿剂血容量减少者,可能会引起血乐过度。故首次"}, {"probability": {"variance": 0.000158, "average": 0.993735, "min": 0.951852}, "location": {"width": 293, "top": 1390, "height": 33, "left": 177}, "words": "剂量应从低剂量开始,或遵医嘱"}, {"probability": {"variance": 0.000112, "average": 0.993707, "min": 0.967209}, "location": {"width": 294, "top": 1428, "height": 34, "left": 239}, "words": "定期做白细胞计数和肾功能检测"}, {"probability": {"variance": 0, "average": 0.854473, "min": 0.854473}, "location": {"width": 56, "top": 1409, "height": 58, "left": 843}, "words": "长"}, {"probability": {"variance": 0.006732, "average": 0.972489, "min": 0.689118}, "location": {"width": 274, "top": 1469, "height": 33, "left": 249}, "words": "本品性状发生改变时禁止使用"}, {"probability": {"variance": 0.000615, "average": 0.978617, "min": 0.931496}, "location": {"width": 156, "top": 1421, "height": 112, "left": 824}, "words": "量管理专用章"}, {"probability": {"variance": 0.000687, "average": 0.987567, "min": 0.908403}, "location": {"width": 348, "top": 1507, "height": 35, "left": 217}, "words": "6.请将本品放在儿童不能接触的地方"}, {"probability": {"variance": 4e-06, "average": 0.998581, "min": 0.993082}, "location": {"width": 241, "top": 1551, "height": 28, "left": 206}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 4.4e-05, "average": 0.994659, "min": 0.983667}, "location": {"width": 149, "top": 1591, "height": 27, "left": 221}, "words": "马来酸依那普利"}, {"probability": {"variance": 0.001555, "average": 0.953208, "min": 0.895216}, "location": {"width": 101, "top": 1613, "height": 40, "left": 1026}, "words": "仅供存档"}], "language": 3}